13 Part VI: Summary of the risk management plan (RMP) - Dorzolamide hydrochloride/Timolol maleate, 20 mg/ml + 5 mg/ml Eye drops, solution

List of important risks and missing information Important Identified Risks • Hyperkalemia Important Potential Risks • Venous Thromboembolism • Bone fracture/Decrease in bone